Alimera Sciences (ALIM) Stock Highlights

5.54 | +0%

2024-11-21 05:05:51

Alimera Sciences Inc is a pharmaceutical company focused on commercializing and developing treatments that address diseases affecting the back of the eye (retina). ILUVIEN is Alimeras a patented micro-implant which delivers a continuous, low dose anti-inflammatory agent to the retina for up to 3 years. DME is often treated with acute therapies when the fluid in the eye returns. ILUVIEN reduces the recurrence of edema to stable vision, with the benefit of continuous treatment due to the products novel drug delivery technology. The company expects to accelerate growth of ILUVIEN through increased penetration of existing markets; expansion into new markets; and a new indication for non-infectious posterior uveitis in the EU.

Statistics

Range Today

5.54 5.54

Volume Today 0

Range 1 Year

2.61 5.65

Volume 1 Year 71.14M

Range 3 Year

1.3 7.92

Volume 3 Year 125M

Range 10 Year

1.3 12.25

Volume 10 Year 148.78M

Highlights

Market Capitalization 301.29M (small)

Floating Shares 13.18M

Current Price 5.54

Price To Earnings 5.29

Price To Revenue 3.64

Price To Book 7.49

Earnings Per Share 1.05

Payout Ratio 0%

Performance

Latest 0%

1 Month -0.72%

3 Months +71.52%

6 Months +30.35%

1 Year +62.46%

3 Years +15.9%

5 Years +23.11%

10 Years +23.11%

Benchmarks

Market Capitalization

34 / 54

Gross Profits

0 / 39

Total Revenue

39 / 50

Total Rank

46 / 54

Free Cashflow

51 / 54

Performance 5 years

13 / 54

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.